Volume 17, Number 10—October 2011
Dispatch
Clostridium difficile Infection in Outpatients, Maryland and Connecticut, USA, 2002–2007
Table 1
Risk factor | No. (%) patients with CDI, n = 43 | No. (%) patients with diarrhea but not CDI, n = 1,048 | p value† |
---|---|---|---|
Illnesses potentially affecting immune status | |||
Lupus | 1 (2.3) | 4 (0.4) | 0.06 |
Cancer under active treatment | 3 (7.0) | 40 (3.8) | 0.30 |
HIV/AIDS | 2 (4.7) | 43 (4.1) | 0.86 |
History of organ transplant | 2 (4.7) | 22 (2.1) | 0.26 |
Chronic obstructive pulmonary disease (on prednisone) | 1 (2.3) | NA | NA |
Illnesses potentially affecting gastrointestinal function | |||
Crohn disease | 0 (0) | 14 (1.3) | 0.45 |
Ulcerative colitis | 1 (2.3) | 19 (1.8) | 0.81 |
Prior bowel or ulcer surgery | 6 (14.0) | 69 (6.6) | 0.06 |
Any medical or surgical condition | 15 (34.9) | 176 (16.8) | 0.002 |
Hospitalized within prior month | 14 (32.6) | 92 (8.8) | <0.001 |
Antimicrobial drug therapy within prior month | 27 (62.8) | 231 (22.0) | <0.001 |
No hospitalization or antimicrobial drug therapy within prior month and no predisposing condition | 7 (16.3) | 698 (66.6) | <0.001
*CDI, Clostridium difficile infection; NA, not available. *CDI, Clostridium difficile infection; NA, not available. |
*CDI, Clostridium difficile infection; NA, not available.
†Uncorrected χ2.
Page created: September 26, 2011
Page updated: September 26, 2011
Page reviewed: September 26, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.